<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><description>药通社：政策、资讯、产业、技术</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 05 Jun 2021 07:44:47 +0800</pubDate><image><url>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</url><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>多个参比制剂二次审议未通过！累计220个审议未通过！CDE45批参比目录公示</title><link>https://mp.weixin.qq.com/s/qMfoPj8eFYJ381jrdXSEmQ</link><description></description><content:encoded><![CDATA[多个参比制剂二次审议未通过！累计220个审议未通过！CDE45批参比目录公示]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>丁劲松教授：改善药物功效与外用制剂创新</title><link>https://mp.weixin.qq.com/s/2UNXC-Vf6Xfn_e_BdMBoRw</link><description></description><content:encoded><![CDATA[丁劲松教授：改善药物功效与外用制剂创新]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>省药监局发布：《药品生产监督检查缺陷整改指南》！</title><link>https://mp.weixin.qq.com/s/y_Co2aJvNxB9utasuC-Gjg</link><description></description><content:encoded><![CDATA[省药监局发布：《药品生产监督检查缺陷整改指南》！]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>Biohaven在研新药Troriluzole胶囊报临床</title><link>https://mp.weixin.qq.com/s/Pe-XncX7JMe3g9cPrRtpWw</link><description></description><content:encoded><![CDATA[Biohaven在研新药Troriluzole胶囊报临床]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>最新全球销售额TOP20药物名单！销售总额超1500亿美元</title><link>https://mp.weixin.qq.com/s/B_u_z4VfKtMsa_lNOOW77g</link><description></description><content:encoded><![CDATA[最新全球销售额TOP20药物名单！销售总额超1500亿美元]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/-mh4rXf31aIzvdEW22c_Xw</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>医药类求职招聘！制药人才网！药企免费发布！</title><link>https://mp.weixin.qq.com/s/2478rlNKHUD62THXhn92MA</link><description></description><content:encoded><![CDATA[医药类求职招聘！制药人才网！药企免费发布！]]></content:encoded><pubDate>Sat, 05 Jun 2021 00:24:14 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/_6BOagqyTPgGxAWb0hLrSg</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>邀请函丨MAH持有人诚邀您莅临改良型新药趋势及技术峰会</title><link>https://mp.weixin.qq.com/s/tuPrMT-qyq7HjU4zJyDMBw</link><description></description><content:encoded><![CDATA[邀请函丨MAH持有人诚邀您莅临改良型新药趋势及技术峰会]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>大奖速递丨你有一份奖品记得领取！</title><link>https://mp.weixin.qq.com/s/7VLAqkVwF2SmxzbRazOmtw</link><description></description><content:encoded><![CDATA[大奖速递丨你有一份奖品记得领取！]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>1大波重磅药品获批！</title><link>https://mp.weixin.qq.com/s/MAbWDjyVP_ZscvBwvjK7Wg</link><description></description><content:encoded><![CDATA[1大波重磅药品获批！]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>岸迈生物BCMA-CD3双抗临床获CDE受理！岸迈第3款双抗!</title><link>https://mp.weixin.qq.com/s/WCl6zVyYnFqM2rzB4fho1g</link><description></description><content:encoded><![CDATA[岸迈生物BCMA-CD3双抗临床获CDE受理！岸迈第3款双抗!]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>新药 | FGFR激酶抑制剂Infigratinib获批，用于特定成年胆管癌患者治疗</title><link>https://mp.weixin.qq.com/s/rCeuPvmcV3yJBp_otSZ73A</link><description></description><content:encoded><![CDATA[新药 | FGFR激酶抑制剂Infigratinib获批，用于特定成年胆管癌患者治疗]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>医药类求职招聘！制药人才网！药企免费发布！</title><link>https://mp.weixin.qq.com/s/GDBGi4S4tUtWQrky839-yg</link><description></description><content:encoded><![CDATA[医药类求职招聘！制药人才网！药企免费发布！]]></content:encoded><pubDate>Fri, 04 Jun 2021 10:01:49 +0800</pubDate></item><item><title>刚刚！长三角、大湾区分中心“招兵买马”！参考事业单位管理！</title><link>https://mp.weixin.qq.com/s/gw2TG-dHZqWR4JMBCPLLTQ</link><description></description><content:encoded><![CDATA[刚刚！长三角、大湾区分中心“招兵买马”！参考事业单位管理！]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item><item><title>邀请函丨最具性价比CRO，诚邀您莅临改良型新药趋势及技术峰会</title><link>https://mp.weixin.qq.com/s/McmQisoJkS-Z6WQrs9mVWA</link><description></description><content:encoded><![CDATA[邀请函丨最具性价比CRO，诚邀您莅临改良型新药趋势及技术峰会]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item><item><title>重磅！最多可入围10家！国采办发布《全国药品集中采购文件（GY-YD2021-2）》</title><link>https://mp.weixin.qq.com/s/vEwq4qUsEltknlDZq6areg</link><description></description><content:encoded><![CDATA[重磅！最多可入围10家！国采办发布《全国药品集中采购文件（GY-YD2021-2）》]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item><item><title>新药 | FGFR激酶抑制剂Infigratinib获批，用于特定成年胆管癌患者治疗</title><link>https://mp.weixin.qq.com/s/45fA8viUDBrFZ9ivt9aSdw</link><description></description><content:encoded><![CDATA[新药 | FGFR激酶抑制剂Infigratinib获批，用于特定成年胆管癌患者治疗]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/uCwmyu0BJgcH6g2MJOAK3w</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item><item><title>医药类求职招聘！制药人才网！药企免费发布！</title><link>https://mp.weixin.qq.com/s/dNffShtqjZvBK0c1a48Vuw</link><description></description><content:encoded><![CDATA[医药类求职招聘！制药人才网！药企免费发布！]]></content:encoded><pubDate>Thu, 03 Jun 2021 09:07:49 +0800</pubDate></item></channel></rss>